GFA
IART icon

Godfrey Financial Associates’s Integra LifeSciences IART Stock Holding History

Godfrey Financial Associates’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359 Hold
20
– – ﹤0.01% 934
2026
Q1 		$188 Hold
20
– – ﹤0.01% 1012
2025
Q4 		$248 Buy
+20
New +$266 ﹤0.01% 943

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Godfrey Financial Associates's IART Position: Q2 2026 in Review

Godfrey Financial Associates held its Integra LifeSciences (IART) position steady in Q2 2026 at 20 shares worth $359. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Godfrey Financial Associates first reported a position in IART in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Godfrey Financial Associates held 20 shares of Integra LifeSciences worth $359 as of Q2 2026.
  • Godfrey Financial Associates left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #934 holding.
  • Godfrey Financial Associates first reported a position in Integra LifeSciences in Q4 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.